Job losses at Bayer Schering

Williams, Dede; Gibson, Jane
February 2007
ICIS Chemical Business;2/26/2007, Vol. 2 Issue 55, p10
Trade Publication
The article reports on the expected downsizing at the Berlin, Germany headquarters of Bayer Schering Pharma. Headcount reductions of 300 in marketing and distribution are already planned, council head Norbert Deutschmann told the German press. Schering employees expected that only 600 jobs would be lost at Berlin. Altogether, Bayer has indicated that 6,000 healthcare jobs will be lost across the two businesses as a result of the merger.


Related Articles

  • Bayer Schering job cuts on target. Williams, Dede // ICIS Chemical Business;6/4/2007, Vol. 2 Issue 69, p11 

    This article states that Bayer Schering Pharma has reached agreement with nearly two-thirds of the Berlin, Germany-based employees who will lose their jobs in the company's merger-related workforce reduction plan. The plan foresees the elimination of 6,100 group positions, including 1,500 in...

  • Schering renamed.  // European Pharmaceutical Executive;Feb/Mar2007, p10 

    The article reports on Germany-based Schering AG's decision to change its name to Bayer Schering Pharma AG. The necessary entry in the commercial register took effect on December 29, 2006. The article also reports that the new logo has been mounted on Bayer Schering Pharma's headquarters in...

  • TOP 20 PHARMA: #15 BAYER SCHERING.  // Contract Pharma;2009, Vol. 11 Issue 6, p84 

    The article profiles Bayer Schering Pharma AG, the rank 15 among the top 20 pharmaceutical companies based in Leverkusen, Germany. It notes that it was founded in 1971 and handles 108,600 employees. It mentions its plan to strengthen its research and development initiative in 2009 through its 4...

  • Schering and Bayer seal drug ownership agreement. Chynoweth, Emma // ICIS Chemical Business;4/2/2007, Vol. 2 Issue 60, p33 

    This article reports that Bayer Schering Pharma and Novartis have settled a dispute over U.S. production of the interferon-based multiple sclerosis treatment Betaseron, sold in the U.S. as Betaferon. The deal sees Bayer Schering Pharma acquiring most of Novartis' Emeryville, California, site,...

  • Bayer Schering job cuts. William, Dede; Gibson, Jane // ICIS Chemical Business Americas;3/5/2007, Vol. 271 Issue 9, p13 

    This article reports that Schering is set to cut 950 jobs at its headquarters in Berlin, Germany by 2009. Werner Wenning, Bayer chairman, said the move is due to the merger between the pharmaceutical activities of Schering and Bayer. Wenning, who is also chairman of Bayer Schering Pharma's...

  • Europe watch.  // ICIS Chemical Business Americas;3/26/2007, Vol. 271 Issue 12, p14 

    The article presents news briefs on chemical producer Bayer as of March 2007. The company reached an agreement with the works council at the Bayer Schering Pharma on an acceptable plan for implementing its job cuts after their merger. Bayer paid $1.2 billion as settlement for 3,152 out-of-court...

  • European pharma consolidation generates quality spinoffs. Sheridan, Cormac // Nature Biotechnology;Dec2006, Vol. 24 Issue 12, p1458 

    The article focuses on the consolidation and acquisition of European pharmaceutical companies. The article discuses that Berlin based Schering company and two German companies are acquired by Bayer Healthcare, Germany, to establish Bayer-Schering Pharma. And the establishment will concentrate on...

  • COMPANY SPOTLIGHT -- Bayer Schering.  // PharmaWatch: CNS;Nov2010, Vol. 9 Issue 11, p19 

    The article features Bayer Schering Pharma AG. It relates that the pharmaceutical company is a research-based company which engaged in the manufacturing, developing, and marketing of pharmaceutical products. It says that the company focuses in four businesses including diagnostic imaging,...

  • BREAKING NEWS.  // Pharmaceutical Technology;Feb2007, Vol. 31 Issue 2, p20 

    The article presents a summary of news events from December 2006 to January 2007 in the pharmaceutical industry, which were published in the "Weekly Electronic Newsletter of Pharmaceutical Technology." In Berlin and Leverkusen, Germany, Bayer Schering Pharma was launched as a start up company...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics